Home Meet Dr. Alptekin
BA (Hons) – MSc – GMBPsS – PhD (DClinPsy)
Specialist Neuropsychologist & (CUBS) Expert Witness for Civil Law
Certified TMS Practitioner – QEEG & Advanced EEG Interpretation Certificate
Dr. Alptekin Aydın, a Specialist Neuropsychologist and Certified TMS Practitioner, was born in 1973 in Moda, Istanbul. After graduating with First-Class Honours (1st) from the Department of Psychology at Istanbul University, he completed his internship in Psychology and Philosophy Teaching Formation at Galatasaray High School. His early research focused on identifying, diagnosing, and treating autism, learning difficulties, and ADHD in children, with a particular emphasis on school adaptation challenges.
Dr. Aydın pursued a Master’s degree in Psychology at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, specializing in Neurological and Pharmacological Substance Addiction. His academic journey continued with a Doctorate (DClinPsy) in Clinical Psychology and Neuroscience in the United States, where he published groundbreaking research titled:
“Assessing the Impact of tDCS Treatment Over the Dorsolateral Prefrontal Cortex (DLPFC) on Social Communication in Children with ASD: A Survey of Family Experiences.”
Dr. Aydın further specialized in neuromodulation by completing the International Clinical TMS Certification program at Maastricht University (UM) in the Netherlands, obtaining accreditation from the European Accreditation Council for Continuing Medical Education (EACCME) as a Certified Transcranial Magnetic Stimulation (TMS) and tDCS practitioner.
In June 2014, Dr. Aydın participated in the Greenwich Beresford Project, a collaborative research effort between the UK Department of Health and King’s College University. In 2015, he extended his expertise to individuals struggling with Gambling Addiction, providing Cognitive Behavioral Therapy through Redcard Gambling. His work expanded to include municipal-level healthcare initiatives, supporting councils such as Haringey, Hackney, and Enfield in developing neuromodulation-based treatment programs for mental health and addiction recovery.
In addition to his contributions to neuromodulation, he received training in Mora Bioresonance (Quantum Frequency Technology) therapy for smoking, alcohol, and substance addiction. As a Certified Bioresonance Practitioner, he has treated over 3,000 adults for substance addiction, integrating his proprietary Neuromodulation TMS, Quantum Frequency Therapy, and Cognitive Behavioral Therapy (CBT) protocols.
In 2018, Dr. Aydın developed and introduced a groundbreaking scientific method known as QPAN (QEEG-Guided Personalized AI-Based Neuromodulation Therapy). This system, utilizing TMS and tDCS for individuals with special needs, was specifically designed for those with: Autism Spectrum Disorder (ASD) Learning Difficulties (Dyslexia, Dyscalculia, Dysgraphia) Epilepsy and Epileptic Wave Regulation Attention Deficit and Hyperactivity Disorder (ADHD) QPAN was the first AI-integrated neuromodulation system worldwide, pioneering a comprehensive therapeutic approach that merges QEEG brain scan technology, AI-driven brain function mapping, and personalized neuromodulation treatment protocols. This multi-disciplinary system integrates: Therapeutic Brain Stimulation (TMS, tDCS, tACS, and Neurofeedback) Cognitive Training & Educational Programs Tailored Sports and Motor Activity Interventions Personalized Nutrition and Metabolic Optimization Since its development, QPAN has successfully been applied to over 5,000 individuals, demonstrating an impressive success rate of 70-85% in improving cognitive function, emotional regulation, and adaptive learning skills.
Dr. Aydın is also the founder and administrator of a private Facebook group with over 9,500 active families worldwide, where patients and caregivers share their experiences, support one another, and discuss ongoing neuromodulation treatments.
His dedication to accessible and inclusive healthcare extends beyond clinical practice—he has worked tirelessly to bridge the gap between cutting-edge neuroscience and real-world applications for families seeking solutions for their loved ones.
In 2022, Dr. Aydın obtained an Expert Witness for Civil Law certification from the Cardiff School of Law and Politics (North Road) in the UK, in collaboration with Bond Solon. As a Specialist Neuropsychologist and Expert Witness, he prepares comprehensive medico-psychological reports based on QEEG functional brain mapping. These reports are:
Scientifically grounded in biological markers.
Used in court cases, Home Office proceedings, and municipal government appeals.
Essential in diagnosing psychological conditions and documenting treatment outcomes.
His expertise in functional brain diagnostics provides valuable insights for legal teams, policymakers, and healthcare institutions, ensuring that neurological conditions are properly understood and accounted for in civil and medical cases.
Between 2022 and 2023, Dr. Aydın completed additional certifications in QEEG Reporting and Program Use in Florida, USA. During this period, he also obtained an Advanced EEG Reading and Interpretation Certificate, reviewing and interpreting thousands of EEGs and QEEG reports to refine diagnostic accuracy for:
Neurodevelopmental Disorders
Treatment-Resistant Depression and Anxiety
Stroke and Neurovascular Impairments
Traumatic Brain Injuries (TBI) and Post-Concussion Syndrome
This extensive experience in functional brain diagnostics and real-time EEG analysis allows him to provide precise, data-driven recommendations for neuromodulation treatment planning.
Dr. Aydın is the founder and owner of Cosmos Healthcare Ltd., the largest Neuromodulation TMS and tDCS clinic in Enfield, England. Cosmos Healthcare provides specialized treatments for:
Autism, ADHD, and Learning Difficulties
Epilepsy and Neurological Pain Management
Depression, Anxiety, and OCD
Stroke Rehabilitation and Post-Injury Neuroplasticity Enhancement
Substance Addiction and Behavioral Health Recovery
In addition to his leadership at Cosmos Healthcare Ltd., Dr. Alptekin Aydın serves as Chairman of the Board at Cosmos Istanbul PLC, an organization dedicated to supporting remote tDCS treatment users worldwide.
Recognizing the growing demand for home-based neuromodulation therapy, Cosmos Istanbul PLC was established to provide technical support, user guidance, and real-time assistance for individuals undergoing tDCS treatments from their homes.
Through this initiative, users of personalized tDCS protocols receive continuous remote monitoring, troubleshooting assistance, and customized protocol adjustments based on their treatment progress. The organization’s global call service ensures that patients, caregivers, and healthcare professionals have access to:
Guidance on protocol adjustments based on qEEG and Neuromap reports.
Immediate assistance for troubleshooting software or hardware-related issues.
Continuous follow-ups.
With a dedicated call centre, Cosmos Istanbul PLC plays a crucial role in making home-based brain stimulation treatments more effective, accessible, and user-friendly. This 24/7 monitoring global support system reflects Dr. Aydın’s commitment to bridging the gap between advanced neuroscience and real-world patient care, ensuring that personalized neuromodulation is not limited to clinic settings but can be safely and effectively implemented in home environments worldwide.
HCPC-Registered Occupational Therapists (Adult & Children)
Certified TMS and tDCS Practitioners
Specialist Psychologists and Addiction Experts
QEEG Reporting and Neurofeedback Specialists
Consultant Speech and Language Therapists (SLT)
Each expert within the Cosmos Healthcare team is committed to delivering world-class, patient-centered care, ensuring that individuals receive not only cutting-edge treatment but also compassionate and effective rehabilitation services.
Dr. Alptekin Aydın’s contributions to neuromodulation, cognitive neuroscience, and mental health treatment have positioned him as a leader in the field of personalized neurostimulation therapies. His research, clinical expertise, and pioneering development of QPAN AI-driven neuromodulation continue to reshape the future of neurological and psychiatric treatment worldwide.
His mission remains clear:
To advance the field of neuroscience through innovation, ethical application of AI, and real-world accessibility.
To provide life-changing treatment solutions that empower individuals and families seeking effective, personalized brain health interventions.
To ensure that the latest advancements in neuromodulation and neuroplasticity research are not just theoretical but are applied in meaningful, transformative ways for people across the globe.
With an unwavering commitment to scientific excellence, patient-centered care, and groundbreaking research, Dr. Aydın and Cosmos Healthcare continue to redefine what is possible in neuromodulation therapy and cognitive optimization.